Golay J - Search Results

1

The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden.

Boross P, Jansen JH, de Haij S, Beurskens FJ, van der Poel CE, Bevaart L, Nederend M, Golay J, van de Winkel JG, Parren PW, Leusen JH. Boross P, et al. Among authors: golay j. Haematologica. 2011 Dec;96(12):1822-30. doi: 10.3324/haematol.2011.047159. Epub 2011 Aug 31. Haematologica. 2011. PMID: 21880632 Free PMC article.

2

Ibrutinib interferes with the cell-mediated anti-tumor activities of therapeutic CD20 antibodies: implications for combination therapy.

Da Roit F, Engelberts PJ, Taylor RP, Breij EC, Gritti G, Rambaldi A, Introna M, Parren PW, Beurskens FJ, Golay J. Da Roit F, et al. Among authors: golay j. Haematologica. 2015 Jan;100(1):77-86. doi: 10.3324/haematol.2014.107011. Epub 2014 Oct 24. Haematologica. 2015. PMID: 25344523 Free PMC article.

3

Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab.

Golay J, Da Roit F, Bologna L, Ferrara C, Leusen JH, Rambaldi A, Klein C, Introna M. Golay J, et al. Blood. 2013 Nov 14;122(20):3482-91. doi: 10.1182/blood-2013-05-504043. Epub 2013 Oct 8. Blood. 2013. PMID: 24106207 Free article.

4

Rituximab-mediated antibody-dependent cellular cytotoxicity against neoplastic B cells is stimulated strongly by interleukin-2.

Golay J, Manganini M, Facchinetti V, Gramigna R, Broady R, Borleri G, Rambaldi A, Introna M. Golay J, et al. Haematologica. 2003 Sep;88(9):1002-12. Haematologica. 2003. PMID: 12969808

5

The role of complement in the therapeutic activity of rituximab in a murine B lymphoma model homing in lymph nodes.

Golay J, Cittera E, Di Gaetano N, Manganini M, Mosca M, Nebuloni M, van Rooijen N, Vago L, Introna M. Golay J, et al. Haematologica. 2006 Feb;91(2):176-83. Haematologica. 2006. PMID: 16461301

6

Effect of alemtuzumab on neoplastic B cells.

Golay J, Manganini M, Rambaldi A, Introna M. Golay J, et al. Haematologica. 2004 Dec;89(12):1476-83. Haematologica. 2004. PMID: 15590398

7

The sensitivity of acute lymphoblastic leukemia cells carrying the t(12;21) translocation to campath-1H-mediated cell lysis.

Golay J, Cortiana C, Manganini M, Cazzaniga G, Salvi A, Spinelli O, Bassan R, Barbui T, Biondi A, Rambaldi A, Introna M. Golay J, et al. Haematologica. 2006 Mar;91(3):322-30. Haematologica. 2006. PMID: 16531255

8

Rituximab: a new therapeutic tool for primary immune thrombocytopenic purpura?

Introna M, Golay J, Barbui T. Introna M, et al. Among authors: golay j. Haematologica. 2003 May;88(5):482-4. Haematologica. 2003. PMID: 12745265 No abstract available.

9

Complement activation determines the therapeutic activity of rituximab in vivo.

Di Gaetano N, Cittera E, Nota R, Vecchi A, Grieco V, Scanziani E, Botto M, Introna M, Golay J. Di Gaetano N, et al. Among authors: golay j. J Immunol. 2003 Aug 1;171(3):1581-7. doi: 10.4049/jimmunol.171.3.1581. J Immunol. 2003. PMID: 12874252

10

FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab.

Carlotti E, Palumbo GA, Oldani E, Tibullo D, Salmoiraghi S, Rossi A, Golay J, Pulsoni A, Foà R, Rambaldi A. Carlotti E, et al. Among authors: golay j. Haematologica. 2007 Aug;92(8):1127-30. doi: 10.3324/haematol.11288. Haematologica. 2007. PMID: 17650444 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

143 results

Search Page

Filters